Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Stability of Amphotericin B in 5% Dextrose Ophthalmic Solution

Author(s):  Peyron Florence, Elias R, Ibrahim E, Amirat-Combralier V, Bues-Charbit M, Balansard G

Issue:  Jul/Aug 1999 - Compounding Parenteral Products
View All Articles in Issue

Page(s):  316-320

Stability of Amphotericin B in 5% Dextrose Ophthalmic Solution Page 1
Stability of Amphotericin B in 5% Dextrose Ophthalmic Solution Page 2
Stability of Amphotericin B in 5% Dextrose Ophthalmic Solution Page 3
Stability of Amphotericin B in 5% Dextrose Ophthalmic Solution Page 4
Stability of Amphotericin B in 5% Dextrose Ophthalmic Solution Page 5

Download in electronic PDF format for $75

Abstract:  The stability of amphotericin B 5 mg/mL in 5% dextrose ophthalmic solution prepared by the Hospital Pharmacy Service was studied in different conditions of storage and use. Admixtures of amphotericin B were aseptically prepared in low-density polyethylene dropper bottles. The stability of amphotericin B was evaluated in ophthalmic dropper bottles stored in a refrigerator, at room temperature, protected from, or exposed to, light. To simulate the effect of exposure to air, some ophthalmic dropper bottles were opened twice daily and two drops were removed. Immediately after preparation, samples were collected to determine the initial drug concentration by high-performance liquid chromatography and to assess pH, osmolality and sterility. The same tests were conducted after four, eight and 15 days of storage in ophthalmic containers opened daily and unopened after eight, 15, 30, 60, 75 and 120 days of storage. Samples were visually inspected daily for signs of physical incompatibility. An additional study was conducted in four ophthalmic containers collected in the ophthalmology unit after eight or 15 days of current patient use testing the same parameters. Ophthalmic containers stored in the refrigerator (the closed and the opened daily set) showed no loss or deterioration of amphotericin B during the corresponding period of storage (120 and 15 days, respectively). We observed precipitation and degradation after 13 days of storage in ophthalmic containers exposed to normal lighting conditions at room temperature, and after 16 days in ophthalmic containers protected from light. There was no appreciable change in pH or osmolality in any of the samples. Microbiological investigation disclosed negative culture results for all samples. This study shows that aseptically prepared amphotericin B ophthalmic solution packaged in low-density polyethylene bottles can be stored safely for up to 120 days when unopened and stored at 4°C and protected from light, for 16 days when stored at 22°C and protected from light and for 13 days when stored at 22°C and exposed to light.

Related Keywords: amphotericin B, degradation, ophtalmic solution, osmolality, pH, precipitation

Related Categories: OPHTHALMICS, PEER-REVIEWED

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Stability of Amphotericin B in 5% Dextrose Ophthalmic Solution
Peyron Florence
, Elias R, Ibrahim E, Amirat-Combralier V, Bues-Charbit M, Balansard G
Jul/Aug 1999
Pg. 316-320

pH Stability of Injectable Fentanyl, Bupivacaine, or Clonidine Solution or a Ternary Mixture in 0.9% Sodium Chloride in Two Types of Polypropylene Syringes
Jappinen Annaliisa L
, Kokki H, Rasi A S, Naaranlahti Toivo J
Nov/Dec 2002
Pg. 471-474

Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations
Allen Loyd V Jr
Nov/Dec 2017
Pg. 481-486

Formulation and Stability of Solutions
Akers Michael J
Jan/Feb 2016
Pg. 41-45

Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48

Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution
Allen Loyd V Jr
Sep/Oct 2010
Pg. 421

Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions
Allen Loyd V Jr
Sep/Oct 2016
Pg. 399-404

Basics of Compounding: Compounding Solutions
Allen Loyd V Jr
Mar/Apr 2000
Pg. 122-125

Amphotericin B 2-mg/mL Ophthalmic Solution
Allen Loyd V Jr
May/Jun 1998
Pg. 223

Amphotericin B 2-mg/mL Ophthalmic Solution
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 185

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Some Studies of the Stability of Compounded Cefazolin Ophthalmic Solution
Kommanaboyina Brahmaiah
, Lindauer Richard F, Rhodes Christopher T, Grady Lee T
Mar/Apr 2000
Pg. 146-149

Extended Stability of Oxytocin in Common Infusion Solutions
Trissel Lawrence A
, Zhang Yanping, Douglass Kate, Kastango Eric
Mar/Apr 2006
Pg. 156-158

Compounding Pharmacies' Potential to Create Graft Storage Solutions for Bypass Surgeries
Guth Michael AS
Sep/Oct 2015
Pg. 367-373

Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate
Allen Loyd V Jr
Nov/Dec 2015
Pg. 508

Amphotericin B 3% Otic Gel
Allen Loyd V Jr
Sep/Oct 2022
Pg. 422

Amphotericin B, Chloramphenicol Palmitate, Hydrocortisone, and Sulfanilamide Otic Powder
Allen Loyd V Jr
Jan/Feb 2009
Pg. 65

Quality Control Analytical Methods: Testing of Electrolytes Solutions
Vu Nicole
Jan/Feb 2009
Pg. 53-55

Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution
Alexander Kenneth S
, Kaushik Sarita
Mar/Apr 2004
Pg. 147-152

Cyclopentolate Hydrochloride 0.5%, Phenylephrine HCl 2.5%, and Tropicamide 0.5% Ophthalmic Solution
Allen Loyd V Jr
Jul/Aug 2021
Pg. 324

Return to Top